Technical Analysis for CVRX - CVRx, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 14.39 | -0.07% | -0.01 |
CVRX closed down 0.07 percent on Thursday, April 25, 2024, on 1.11 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Apr 30
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Death Cross | Bearish | -0.07% | |
| Doji - Bullish? | Reversal | -0.07% | |
| Lower Bollinger Band Walk | Weakness | -0.07% | |
| Wide Bands | Range Expansion | -0.07% | |
| Oversold Stochastic | Weakness | -0.07% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 6 hours ago |
| Outside Day | about 6 hours ago |
| Up 2% | about 6 hours ago |
| Up 1% | about 7 hours ago |
| 60 Minute Opening Range Breakout | about 8 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 04/30/2024
CVRx, Inc. develops an implantable technology for the treatment of high blood pressure/hypertension and heart failure patients. It offers BAROSTIM NEO, a neuro-modulation therapy that triggers the body's natural reflex to regulate blood pressure and the underlying causes of the progression of heart failure, which is delivered through a long-lasting implant system, and customized to each patient's individual therapy needs. The company serves patients and healthcare professionals. CVRx, Inc. was incorporated in 2000 and is based in Minneapolis, Minnesota. It has operations in the United States, the United Kingdom, the Netherlands, Italy, Germany, and internationally.
Sector: Healthcare
Industry: Medical Devices
Keywords: Hypertension Medical Device Heart Failure Organ Failure Heart
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Hypertension Medical Device Heart Failure Organ Failure Heart
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 33.135 |
| 52 Week Low | 9.9201 |
| Average Volume | 127,556 |
| 200-Day Moving Average | 19.46 |
| 50-Day Moving Average | 19.17 |
| 20-Day Moving Average | 16.67 |
| 10-Day Moving Average | 15.39 |
| Average True Range | 0.94 |
| RSI (14) | 25.93 |
| ADX | 36.3 |
| +DI | 9.86 |
| -DI | 36.82 |
| Chandelier Exit (Long, 3 ATRs) | 16.42 |
| Chandelier Exit (Short, 3 ATRs) | 16.39 |
| Upper Bollinger Bands | 19.72 |
| Lower Bollinger Band | 13.62 |
| Percent B (%b) | 0.13 |
| BandWidth | 36.57 |
| MACD Line | -1.47 |
| MACD Signal Line | -1.31 |
| MACD Histogram | -0.1632 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 16.07 | ||||
| Resistance 3 (R3) | 15.98 | 15.34 | 15.79 | ||
| Resistance 2 (R2) | 15.34 | 14.91 | 15.38 | 15.70 | |
| Resistance 1 (R1) | 14.86 | 14.64 | 15.10 | 14.95 | 15.60 |
| Pivot Point | 14.22 | 14.22 | 14.34 | 14.26 | 14.22 |
| Support 1 (S1) | 13.74 | 13.79 | 13.98 | 13.83 | 13.18 |
| Support 2 (S2) | 13.10 | 13.52 | 13.14 | 13.08 | |
| Support 3 (S3) | 12.62 | 13.10 | 12.99 | ||
| Support 4 (S4) | 12.71 |
